Han Xue, Liao Lijun, Zhu Tian, Xu Yuchan, Bi Fei, Xie Li, Li Hui, Huo Fangjun, Tian Weidong, Guo Weihua
Engineering Research Center of Oral Translational Medicine, Ministry of Education, West China Hospital of Stomatology, Sichuan University, Chengdu, China; National Engineering Laboratory for Oral Regenerative Medicine, West China Hospital of Stomatology, Sichuan University, Chengdu, China; State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China; National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China; Department of Pediatric Dentistry, West China School of Stomatology, Sichuan University, Chengdu, China.
Engineering Research Center of Oral Translational Medicine, Ministry of Education, West China Hospital of Stomatology, Sichuan University, Chengdu, China; National Engineering Laboratory for Oral Regenerative Medicine, West China Hospital of Stomatology, Sichuan University, Chengdu, China; State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China; National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China.
Mater Sci Eng C Mater Biol Appl. 2020 Nov;116:111224. doi: 10.1016/j.msec.2020.111224. Epub 2020 Jun 20.
Host immune response to tissue engineering tissues or organs directly determines the graft survival and the integration with host. Our and other previous studies have successfully regenerated the organs/tissues based on allogeneic native decellularized matrix (aNDM). But the very limited aNDM clinically hinders the artificial organs/tissues application to resolve the native organs/tissues loss with high incidence. However, the xenogeneic NDM will induce host immune rejection leading to the transplantation failure. This study constructed the xenogeneic (porcine) NDM (xNDM) which carried the immunoregulator Rosiglitazone (xNDM-RSG), a synthetic highly selective agonist of peroxisome proliferator-activated receptor-γ (PPARγ), evaluated xNDM's physical and chemical characterization, immunomodulatory properties, and its effect on the tissue regeneration. Results showed that the xNDM-RSG did not affect the proliferation and differentiation of odontogenic stem cells. In addition, the xNDM-RSG could also effectively decrease the expression of IL-1 and TNFα, and increase the expression of IL-10 and TGFβ to enable a favorable immunomodulation and promote the ligament-to-bone regeneration by PPARγ to induce the alternative activated macrophages (M2 macrophages) antagonizing classically activated macrophages (M1 macrophages). Meanwhile the xNDM-RSG obviously reduces the implants absorption and promotes the regenerated ligament-to-bone expressing the key proteins (ALP, OPN, DSP) which are relative to the native dental and bone. This study demonstrated that protein adsorption could aggravate the immune inflammatory reaction, whereas, xNDM-RSG could effectively control the host immune response to accelerate tissue reparation and regeneration by facilitating the macrophage polarization, which highlighted a new strategy for improving the transplantation survival of the artificial organ or tissue based on the xenogeneic decellularized biomaterials.
宿主对组织工程组织或器官的免疫反应直接决定了移植物的存活以及与宿主的整合。我们和其他先前的研究已成功基于同种异体天然去细胞化基质(aNDM)再生了器官/组织。但临床上aNDM数量非常有限,这阻碍了人工器官/组织用于解决高发性天然器官/组织缺失问题。然而,异种NDM会引发宿主免疫排斥,导致移植失败。本研究构建了携带免疫调节剂罗格列酮(xNDM-RSG)的异种(猪)NDM(xNDM),罗格列酮是过氧化物酶体增殖物激活受体-γ(PPARγ)的合成高选择性激动剂,评估了xNDM的物理和化学特性、免疫调节特性及其对组织再生的影响。结果表明,xNDM-RSG不影响牙源性干细胞的增殖和分化。此外,xNDM-RSG还能有效降低IL-1和TNFα的表达,并增加IL-10和TGFβ的表达,以实现良好的免疫调节,并通过PPARγ诱导替代活化巨噬细胞(M2巨噬细胞)对抗经典活化巨噬细胞(M1巨噬细胞),从而促进韧带-骨再生。同时,xNDM-RSG明显减少植入物吸收,并促进再生韧带-骨表达与天然牙齿和骨骼相关的关键蛋白(ALP、OPN、DSP)。本研究表明,蛋白质吸附会加剧免疫炎症反应,而xNDM-RSG可通过促进巨噬细胞极化有效控制宿主免疫反应,加速组织修复和再生,这突出了一种基于异种去细胞生物材料提高人工器官或组织移植存活率的新策略。